GLOW is a healing & repair research compound currently in stock directly from a verified Chinese manufacturer. Every batch is HPLC-verified and shipped with a Certificate of Analysis (COA). Sourcing is direct — no intermediaries. Minimum order value is $600 USD. International shipping available.
GLOW is a pre-mixed lyophilized research formulation containing three compounds: TB-500 (Thymosin Beta-4 synthetic analogue), BPC-157 (Body Protection Compound-157), and GHK-Cu (copper peptide Gly-His-Lys with Cu²⁺). The formulation is positioned for research into dermal regeneration, angiogenesis, and tissue remodelling. Each component contributes a distinct mechanistic layer: TB-500 drives actin-dependent cell migration and anti-inflammatory signalling critical for wound closure; BPC-157 promotes angiogenesis and growth factor upregulation required for vascular ingrowth into repairing tissue; GHK-Cu stimulates collagen and elastin synthesis, matrix metalloproteinase (MMP) regulation, and antioxidant gene expression in fibroblasts and keratinocytes.
The dermatological and connective tissue research interest in this combination is based on the observation that optimal wound healing requires three overlapping processes that each compound addresses: vascular supply (BPC-157 via VEGF/NO), cellular migration and proliferation (TB-500 via G-actin/ILK), and extracellular matrix remodelling (GHK-Cu via MMP-1, -2, TIMP regulation, collagen I/III synthesis). Human fibroblast, keratinocyte, and dermal microvascular endothelial cell (HMVEC) models are standard in vitro formats for characterising each component's contribution, with scratch-wound assays, tube formation assays, and hydroxyproline-based collagen quantification as primary endpoints.
PeptidesFromChina.co supplies GLOW as lyophilized powder in sealed vials. Each component is purity-verified by HPLC before blending. Certificates of Analysis available per batch. Wholesale quantities on request. For laboratory research use only.
| Formulation Type | Pre-mixed Lyophilized Research Blend |
|---|---|
| Component 1 | TB-500 (Thymosin Beta-4 fragment) |
| Component 2 | BPC-157 (Body Protection Compound-157) |
| Component 3 | GHK-Cu (Glycyl-L-histidyl-L-lysine : Cu²⁺) |
| TB-500 Mechanism | Cell migration (G-actin), ILK activation, anti-inflammatory |
| BPC-157 Mechanism | Angiogenesis (VEGF/NO), cytoprotection, growth factor signalling |
| GHK-Cu Mechanism | Collagen/elastin synthesis, MMP regulation, antioxidant gene expression |
| Research Category | Skin & Hair, Tissue Repair, Angiogenesis, ECM Remodelling |
| Storage | -20°C lyophilized; 4°C reconstituted (up to 14 days) |
| CAS Number | N/A — combination product |
| Molecular Weight | N/A — see individual component COAs |
| Molecular Formula | N/A — combination product |
| Sequence | N/A — combination product |
| Name | Strength | Pack Size | Purity | Availability | Price (USD) |
|---|---|---|---|---|---|
| GLOW | 70 mg | 10 vials | ≥98% | In Stock | $219.00 |
Testing method: HPLC / LC-MS. Every batch is tested before shipment. Purity ≥99% confirmed per batch.
Certificate of Analysis (COA) is included with every order. Documentation covers purity, molecular weight, and batch identification.
Dermal wound healing research using the GLOW combination addresses the three phases of repair: inflammation, proliferation, and remodelling. TB-500's anti-inflammatory (NF-κB suppression) and migration-promoting (actin remodelling) activity is characterised in scratch-wound closure assays in human dermal fibroblast (HDF) and keratinocyte (HaCaT) cell lines. BPC-157 is studied for VEGF-driven angiogenesis using human microvascular endothelial tube formation assays. GHK-Cu's effects on collagen type I, III, and elastin mRNA (by RT-PCR) and protein secretion (by Sircol collagen assay) are measured in 3D fibroblast-populated collagen lattice (FPCL) and dermal equivalent models.
Vascularisation of healing tissue is rate-limiting in deep dermal and full-thickness wounds. BPC-157 upregulates VEGFR-2 expression and stimulates NO-mediated vasodilation, characterised using human umbilical vein endothelial (HUVEC) and dermal microvascular endothelial cell tube formation assays (Matrigel basement membrane extract). TB-500's Ac-SDKP tetrapeptide active sequence also promotes endothelial cell chemotaxis in transwell migration assays. The combination's angiogenic synergy — whether BPC-157 and TB-500 together produce greater tube formation than either alone — is a quantifiable primary endpoint using total tube length and branch point counting via automated microscopy.
GHK-Cu is a naturally occurring tripeptide-copper complex found in human plasma that increases in concentration at sites of tissue injury. Research demonstrates that GHK-Cu stimulates fibroblast expression of collagen I, collagen III, fibronectin, and elastin while simultaneously regulating MMP-1, MMP-2, and their tissue inhibitors (TIMPs) — a balanced ECM remodelling profile that avoids excessive fibrosis. The copper ion (Cu²⁺) component contributes to antioxidant enzyme (superoxide dismutase, ceruloplasmin) upregulation in fibroblasts. Gene expression studies using Affymetrix microarray have characterised GHK-Cu's broad genomic effects in human fibroblasts, including upregulation of over 100 genes involved in repair and tissue organisation.
The skin barrier's structural integrity depends on keratinocyte proliferation, differentiation, and tight junction protein expression. In organotypic skin equivalent models (reconstructed human epidermis on dermal equivalents), the GLOW combination is studied for effects on epidermal thickness, keratinocyte differentiation markers (involucrin, filaggrin, loricrin), and barrier permeability (TEER measurements and dye permeation assays). GHK-Cu's established photoprotective effects in UVB-irradiated keratinocyte models (reduced CPD formation, p53 accumulation, and oxidative stress markers) are examined alongside BPC-157 and TB-500's anti-inflammatory contributions to post-UV repair.
Wolverine Blend contains only BPC-157 and TB-500, targeting general tissue repair across musculoskeletal, GI, and vascular systems. GLOW adds GHK-Cu to this base combination, extending the research profile into extracellular matrix remodelling, collagen synthesis regulation, and dermal-specific biology. GLOW is categorised for skin, hair, and connective tissue research, where GHK-Cu's established fibroblast activity provides a third mechanistic layer beyond the vascular (BPC-157) and migration (TB-500) components.
Yes. The Cu²⁺ ion in GHK-Cu is integral to its biological activity — decomplexed GHK without copper shows significantly reduced fibroblast activation in collagen synthesis assays. The copper is present at a 1:1 molar ratio with the GHK tripeptide. In cell culture, the copper concentration delivered by GHK-Cu at research doses (1–100 nM) is within the range of endogenous serum copper and does not produce cytotoxicity in standard fibroblast and keratinocyte viability assays (MTT, LDH release). Copper-specific effects can be distinguished from peptide-specific effects using decomplexed GHK as a comparator.
Each component — TB-500, BPC-157, and GHK-Cu — is individually verified by RP-HPLC (≥98% purity) and ESI-MS identity confirmation before blending. The lyophilized blend is produced under controlled conditions to ensure homogeneous mixing. Certificates of Analysis for each component and the combined blend batch are available upon request.
Yes. GLOW is available through PeptidesFromChina.co on a B2B wholesale basis. Pricing and minimum order quantities are provided on request after account verification. Contact us via the Request page.
For laboratory research use only. Not for human or veterinary use. PeptidesFromChina.co is a B2B wholesale supplier operating under strict research-use-only terms. All products are sold exclusively for in vitro and preclinical research purposes.